Company / R&D per Share
PROKIDNEY CORP. R&D per Share History
FY2022-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.33
FY2022
5-year range
$1.33 / $1.33
FY2022-FY2022
Trend
-
vs FY2021
Sector context
#133 of 208
Health Care
What the data says
At $1.33, PROKIDNEY CORP.'s r&d per share ranks #133 of 208 in the Health Care sector.
Based on SEC 10-K filings.
1.33 in FY2022.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 208 in Health CareTop 64% of 208This company $1.33 Sector average $28.82
▼
-95.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $1.33 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026